Dr Fares Qeadan, the paper’s primary author, explains to Popular Science that opioids and alcohol were chosen for the study ...

Ozempic could cut binge drinking and opioid abuse, major research suggests. A US study of more than 800,000 people with a ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...

Biologists at Brown University have discovered how a neuropeptide hormone made in the gut of flies can control their lifespan ...

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders.

GLP-1 (Glucagon-Like Peptide-1) receptor agonists, including semaglutide, are marketed under names like Ozempic and Wegovy.

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...